Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

NCT06765265 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

152

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndromes

Interventions

DRUG: Rosuvastatin 20 mg/day
DRUG: Atorvastatin 40 mg

Sponsor

King Edward Medical University